Compare · NNNN vs TKNO
NNNN vs TKNO
Side-by-side comparison of Anbio Biotechnology (NNNN) and Alpha Teknova Inc. (TKNO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both NNNN and TKNO operate in Biotechnology: In Vitro & In Vivo Diagnostic Substances (Health Care), so they compete in similar markets.
- NNNN is the larger of the two at $2.48B, about 9.9x TKNO ($249.3M).
- Over the past year, NNNN is up 111.7% and TKNO is down 21.9% - NNNN leads by 133.6 points.
- TKNO has been more active in the news (4 items in the past 4 weeks vs 1 for NNNN).
- TKNO has more recent analyst coverage (7 ratings vs 0 for NNNN).
PerformanceNNNN+111.73%TKNO-21.86%
2025-06-09+0.00%2026-06-08
- Company
- Anbio Biotechnology
- Alpha Teknova Inc.
- Price
- $18.23-34.52%
- $4.63+1.87%
- Market cap
- $2.48B
- $249.3M
- 1M return
- -30.41%
- +15.61%
- 1Y return
- +111.73%
- -21.86%
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- 2021
- News (4w)
- 1
- 4
- Recent ratings
- 0
- 7
Latest NNNN
- SEC Form 6-K filed by Anbio Biotechnology
- SEC Form 6-K filed by Anbio Biotechnology
- Amendment: SEC Form 20-F/A filed by Anbio Biotechnology
- SEC Form 3 filed by new insider Song Suki
- SEC Form 3 filed by new insider Hartzler Nancy
- SEC Form 3 filed by new insider Lau Michael
- SEC Form 3 filed by new insider Tian Chris
- SEC Form 3 filed by new insider Xu Cany
- SEC Form 20-F filed by Anbio Biotechnology
- Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum
Latest TKNO
- SEC Form 4 filed by Director Vos Alexander
- SEC Form 4 filed by Director Robertson Brett
- SEC Form 4 filed by Director Demski Martha J
- Alpha Teknova Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- SEC Form 10-Q filed by Alpha Teknova Inc.
- Alpha Teknova Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits, Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
- Teknova Reports First Quarter 2026 Financial Results
- Teknova to Report First Quarter 2026 Financial Results on May 6, 2026
- SEC Form DEFA14A filed by Alpha Teknova Inc.
- SEC Form DEF 14A filed by Alpha Teknova Inc.